全球先兆子痫诊断市场研究报告 - 2023-2030 年行业分析、规模、份额、增长、趋势和预测

全球对先兆子痫诊断市场的需求将从2022年的13.7332亿美元增长到2030年的41.7769亿美元，2023-2030年调查期间的复合年增长率为14.92%，预计将达到

先兆子痫是妊娠期高血压综合症的一种，据称全球约有5%的孕妇受累，其中0.5%至1%会发展为重症。 妊娠20週后，新发的高血压和蛋白尿是先兆子痫的诊断标准。

市场动态

全球先兆子痫诊断市场主要受先兆子痫发病率上升的推动。 由于对其检测和治疗的需求不断增加，先兆子痫诊断市场预计将扩大。 随着孕产妇和围产期死亡率和发病率的上升，预计对孕妇早期检测先兆子痫的需求将会增加。 此外，检测先兆子痫生物标誌物的新测试的研发进展有望推动市场增长。 此外，医疗保健提供者对这种疾病的有效筛查工具的认识不断提高，以及对孕妇先兆子痫相关症状和体征的了解不断增加，这些都在迅速推动先兆子痫诊断市场的发展。预计

这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还对全球先兆子痫诊断市场的每个部分进行了全面评估。 先兆子痫诊断行业的发展和趋势为这项研究提供了一种整体方法。

市场细分

本部分提供有关国家/地区细分市场的详细数据，以帮助战略制定者确定各自产品和服务的目标受众，并将他们与未来的商机联繫起来。.

按测试类型

• 验血
• 尿液分析

按产品类型

• 仪器
• 消耗品

由最终用户

• 医院
• 专科门诊
• 诊断中心
• 其他

区域分析

本节对北美、欧洲、亚太地区、拉丁美洲、中东和非洲的先兆子痫诊断市场的当前和未来需求进行区域展望。 此外，该报告重点关注所有主要地区每个单独应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 先兆子痫诊断市场的主要参与者是 F. Hoffmann-La Roche Ltd.、PerkinElmer Inc.、DRG INSTRUMENTS GMBH、Thermo Fisher Scientific Inc.、Diabetomics, Inc.、Metabolomics Diagnostics Ltd.、Sera Prognostics、Siemens Healthineers AG，□□例如Bayer AG。 本节全面介绍了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

如果您有任何定制要求，请告诉我们。 我们的研究团队可以根据您的需要提供定制报告。

内容

第一章前言

• 报告内容
  • 目的
  • 目标受众
  • USP（独特的销售建议）及其提供的内容
• 调查范围
• 调查方法
  • 市场调研流程
  • 市场研究方法

第 2 章执行摘要

• 市场亮点
• 全球市场概况

第 3 章先兆子痫诊断 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场製约因素
• 机会
• 行业趋势
• 波特的五力分析
• 市场吸引力分析
  • 按测试类型
  • 按产品类型
  • 最终用户
  • 按地区

第四章价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料製造商名单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章按测试类型分列的全球先兆子痫诊断市场分析

• 按测试类型汇总
• 过去和未来的数据
• 按测试类型分析
• 血液检测市场：按地区
• 尿液分析市场：按地区

第 7 章按产品类型分列的全球先兆子痫诊断市场分析

• 摘要：按产品类型
• 过去和未来的数据
• 分析：按产品类型
• 仪器市场：按地区
• 消费市场：按地区

第 8 章先兆子痫诊断的全球市场分析：按最终用户分类

• 最终用户总结
• 过去和未来的数据
• 最终用户分析
• 医院市场：按地区
• 专科诊所市场：按地区
• 诊断中心市场：按地区
• 其他市场：按地区

第 9 章先兆子痫诊断的全球市场分析：按地区

• 区域展望
• 简介
• 北美
  • 摘要、实际数据、预测数据
  • 按北美细分
  • 北美：按国家/地区列出
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 摘要、实际数据、预测数据
  • 欧洲（按细分市场）
  • 欧洲：按国家/地区分类
  • 英国
  • 法国
  • 德国
  • 意大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 摘要、实际数据、预测数据
  • 按亚太地区细分
  • 亚太地区：国家/地区信息
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚
  • 其他亚太地区
• 拉丁美洲
  • 摘要、实际数据、预测数据
  • 拉丁美洲细分市场
  • 拉丁美洲：按国家/地区列出
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲地区
• 中东和非洲
  • 摘要、实际数据、预测数据
  • 中东和非洲分部信息
  • 中东和非洲：按国家/地区列出
  • 沙特阿拉伯
  • 阿联酋
  • 以色列
  • 南非
  • 其他中东和非洲地区

第十章子痫前期诊断企业竞争格局

• 先兆子痫诊断市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他扩展

第11章公司简介

• 公司股票分析
• 市场集中度
• F. Hoffmann-La Roche Ltd.
  • 公司概况
  • 产品介绍
  • 近期趋势
• PerkinElmer Inc.
  • 公司简介
  • 产品介绍
  • 近期趋势
• DRG Instruments GMBH
  • 公司简介
  • 产品介绍
  • 近期趋势
• Thermo Fisher Scientific Inc.
  • 公司简介
  • 产品介绍
  • 近期趋势
• Diabetomics, Inc.
  • 公司简介
  • 产品介绍
  • 近期趋势
• Metabolomic Diagnostics Ltd.
  • 公司简介
  • 产品介绍
  • 近期趋势
• Sera Prognostics
  • 公司简介
  • 产品介绍
  • 近期趋势
• Siemens Healthineers AG
  • 公司简介
  • 产品介绍
  • 近期趋势
• Bayer AG
  • 公司简介
  • 产品介绍
  • 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

The global demand for Preeclampsia Diagnostics Market is presumed to reach the market size of nearly USD 4177.69 MN by 2030 from USD 1373.32 MN in 2022 with a CAGR of 14.92% under the study period 2023 - 2030.

Preeclampsia is a hypertension condition of pregnancy that affects roughly 5% of all pregnant women worldwide, with 0.5 percent to 1% developing severe cases. After 20 weeks of pregnancy, new development of high blood pressure and proteinuria are diagnostic criteria for preeclampsia.

Market Dynamics

The global preeclampsia Diagnostics market is primarily driven by rising preeclampsia incidences. The market for preeclampsia diagnostics is predicted to expand due to the constantly increasing need for its detection and treatment. The demand for early detection of preeclampsia among pregnant women is expected to rise as maternal and perinatal death, and morbidity rates rise. Furthermore, the growing research and development of new tests to detect biomarkers that indicate preeclampsia are likely to promote market growth. Moreover, rising healthcare provider awareness of effective screening tools for the illness, and growing knowledge of the signs and symptoms related to preeclampsia among expecting mothers, are expected to propel the preeclampsia diagnostics market forward at a quick pace.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of preeclampsia diagnostics. The growth and trends of preeclampsia diagnostics industry provide a holistic approach to this study.

Market Segmentation

This section of the preeclampsia diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

• Blood Tests
• Urine Analysis

By Product Type

• Instruments
• Consumables

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Preeclampsia Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preeclampsia diagnostics market include F. Hoffmann-La Roche Ltd., PerkinElmer Inc., DRG INSTRUMENTS GMBH, Thermo Fisher Scientific Inc., Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Siemens Healthineers AG, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PREECLAMPSIA DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Test Type
  • 3.7.2 By Product Type
  • 3.7.3 By End-user
  • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

• 6.1 Overview by Test Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Test Type
• 6.4 Blood Tests Market by Regions
• 6.5 Urine Analysis Market by Regions

7 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

• 7.1 Overview by Product Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Product Type
• 7.4 Instruments Market by Regions
• 7.5 Consumables Market by Regions

8 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY END-USER

• 8.1 Overview by End-user
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-user
• 8.4 Hospitals Market by Regions
• 8.5 Specialty Clinics Market by Regions
• 8.6 Diagnostic Centers Market by Regions
• 8.7 Others Market by Regions

9 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America
  • 9.3.1. Overview, Historic and Forecast Data
  • 9.3.2. North America By Segment
  • 9.3.3. North America By Country
  • 9.3.4. United State
  • 9.3.5. Canada
  • 9.3.6. Mexico
• 9.4. Europe
  • 9.4.1. Overview, Historic and Forecast Data
  • 9.4.2. Europe by Segment
  • 9.4.3. Europe by Country
  • 9.4.4. United Kingdom
  • 9.4.5. France
  • 9.4.6. Germany
  • 9.4.7. Italy
  • 9.4.8. Russia
  • 9.4.9. Rest Of Europe
• 9.5. Asia Pacific
  • 9.5.1. Overview, Historic and Forecast Data
  • 9.5.2. Asia Pacific by Segment
  • 9.5.3. Asia Pacific by Country
  • 9.5.4. China
  • 9.5.5. India
  • 9.5.6. Japan
  • 9.5.7. South Korea
  • 9.5.8. Australia
  • 9.5.9. Rest Of Asia Pacific
• 9.6. Latin America
  • 9.6.1. Overview, Historic and Forecast Data
  • 9.6.2. Latin America by Segment
  • 9.6.3. Latin America by Country
  • 9.6.4. Brazil
  • 9.6.5. Argentina
  • 9.6.6. Peru
  • 9.6.7. Chile
  • 9.6.8. Rest of Latin America
• 9.7. Middle East & Africa
  • 9.7.1. Overview, Historic and Forecast Data
  • 9.7.2. Middle East & Africa by Segment
  • 9.7.3. Middle East & Africa by Country
  • 9.7.4. Saudi Arabia
  • 9.7.5. UAE
  • 9.7.6. Israel
  • 9.7.7. South Africa
  • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE PREECLAMPSIA DIAGNOSTICS COMPANIES

• 10.1. Preeclampsia Diagnostics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF PREECLAMPSIA DIAGNOSTICS INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. F. Hoffmann-La Roche Ltd.
  • 11.3.1. Company Overview
  • 11.3.2. Financials
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. PerkinElmer Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financials
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. DRG Instruments GMBH
  • 11.5.1. Company Overview
  • 11.5.2. Financials
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Thermo Fisher Scientific Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financials
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Diabetomics, Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financials
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Metabolomic Diagnostics Ltd.
  • 11.8.1. Company Overview
  • 11.8.2. Financials
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Sera Prognostics
  • 11.9.1. Company Overview
  • 11.9.2. Financials
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Siemens Healthineers AG
  • 11.10.1. Company Overview
  • 11.10.2. Financials
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Bayer AG
  • 11.11.1. Company Overview
  • 11.11.2. Financials
  • 11.11.3. Products
  • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Test Type (USD MN)
• Blood Tests Market by Geography (USD MN)
• Urine Analysis Market by Geography (USD MN)
• Analysis Market by Product Type (USD MN)
• Instruments Market by Geography (USD MN)
• Consumables Market by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals Market by Geography (USD MN)
• Specialty Clinics Market by Geography (USD MN)
• Diagnostic Centers Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Preeclampsia Diagnostics Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Preeclampsia Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Preeclampsia Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Test Type
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Test Type (USD MN)
• Blood Tests Market by Geography (USD MN)
• Urine Analysis Market by Geography (USD MN)
• Global Market Analysis by Product Type (USD MN)
• Instruments Market by Geography (USD MN)
• Consumables Market by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals Market by Geography (USD MN)
• Specialty Clinics Market by Geography (USD MN)
• Diagnostic Centers Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC